Murray Robinson

Murray Robinson is an accomplished leader in the biotechnology and pharmaceutical sectors, currently serving as CEO of Rubik Therapeutics and President of Molquant, Incorporated. Robinson has held significant roles including Chief Scientific Officer at Medisix Therapeutics Pte Ltd., and was the Founder of Molquant, Inc., where innovative approaches to molecular analysis were developed to enhance the interpretation of genomic data. With extensive experience in oncology drug discovery, Robinson's previous positions included senior leadership roles at AVEO Pharmaceuticals and Amgen, where strategic direction in translational medicine and cancer biology were established. Robinson earned a PhD in Molecular Biology from Caltech, complementing a strong academic background in biochemistry and cell biology from Johns Hopkins University and UC San Diego.